Inici › Melanoma › Ohio › Columbus
Assaigs clínics de Melanoma a Columbus, OH
21 estudis de Melanoma busquen participants en centres de Columbus i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutantEstudi observacionalVoluntaris sans benvinguts
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- The Mark H Zangmeister Center, Columbus
- i 8 més
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
ReclutantFase 3
- The Ohio State University Wexner Medical Center, Columbus
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
ReclutantFase 3
- Ohio State University, Columbus
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
ReclutantFase 3
- Ohio State University Comprehensive Cancer Center, Columbus
Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
ReclutantFase 1
- Ohio State University, Columbus
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
ReclutantFase 2
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- Columbus Oncology and Hematology Associates Inc, Columbus
- i 15 més
Project: Every Child for Younger Patients With Cancer
ReclutantEstudi observacional
- Nationwide Children's Hospital, Columbus
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
ReclutantFase 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma
ReclutantFase 1
- Ohio State University Comprehensive Cancer Center, Columbus
Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain
ReclutantFase 1/2
- Ohio State University Comprehensive Cancer Center, Columbus
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
ReclutantFase 1/2
- Ohio State University Wexner Medical Center Gynecologic Oncology at Mill Run, Columbus
Neoadjuvant Darovasertib in Primary Uveal Melanoma
ReclutantFase 3
- Ohio State Eye and Ear Institute, Columbus
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
ReclutantFase 2/3
- The Ohio State University, Columbus
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
ReclutantEstudi observacional
- Memorial Hospital, Marysville · a 27 mi
EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers
ReclutantFase 2
- Ohio State University Comprehensive Cancer Center, Columbus
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
ReclutantEstudi observacionalVoluntaris sans benvinguts
- The Ohio State University Wexner Medical Center, Columbus
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
ReclutantFase 3
- The Ohio State University Comprehensive Cancer Center, Columbus
A Storage Facility for Tissues Obtained From Patients With Malignant Melanoma
ReclutantEstudi observacionalVoluntaris sans benvinguts
- Ohio State University Comprehensive Cancer Center, Columbus
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
ReclutantFase 3
- Ohio State University Wexner Medical Center, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutantEstudi observacional
- Massive Bio SYNERGY-AI site, Columbus
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Reclutant
- Ohio State University Comprehensive Cancer Center, Columbus
Assaigs de Melanoma en altres ciutats
- Houston, TX59 estudis
- New York City, NY38 estudis
- Los Angeles, CA34 estudis
- Nashville, TN33 estudis
- Pittsburgh, PA31 estudis
- Boston, MA26 estudis
- Philadelphia, PA23 estudis
- San Francisco, CA22 estudis
- Durham, NC21 estudis
- Atlanta, GA21 estudis
- St. Louis, MO21 estudis
- Salt Lake City, UT21 estudis
Altres estudis a Columbus
- Càncer de pulmó de cèl·lules no petites56 estudis
- Càncer de mama39 estudis
- Càncer d'ovari39 estudis
- Càncer (tots els tipus)38 estudis
- Càncer de pulmó37 estudis
- Leucèmia mieloide aguda35 estudis
- Leucèmia limfàtica crònica28 estudis
- Càncer metastàtic27 estudis
- Càncer d'endometri25 estudis
- Càncer colorrectal24 estudis
- Càncer de pròstata24 estudis
- Mieloma múltiple24 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.